Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance.
- NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_assertion description "[S100P has been shown to mediate tumor growth, metastasis and invasion through the binding of Ca(2+) ions, receptor for advanced glycation end products, cytoskeletal protein ezrin, calcyclin-binding protein/Siah-1-interacting protein and cathepsin D. S100P could potentially serve as diagnostic marker, prognostic/predictive indicator and therapy target for different carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance.
- NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_assertion evidence source_evidence_literature NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance.
- NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_assertion SIO_000772 21947242 NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance.
- NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_assertion wasDerivedFrom befree-20140225 NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance.
- NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_assertion wasGeneratedBy ECO_0000203 NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance.
- befree-20140225 importedOn "2014-02-25" NP657416.RAPgctdXcr1Q3YnSGEmb4K33OOyH3bA7YThaJS32GFv9c130_provenance.